CLINICAL_TRIALS
trial_result
· 2023-02-16
Clinical Trial Update: Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids [Phase 4]
Summary
Phase 4 trial update on naloxegol to prevent opioid-induced constipation in critically ill adults; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tufts Medical Center | Conditions: Constipation | Phase 4 | Status: TERMINATED | Results posted: 2023-02-16